{"id":"https://openalex.org/W7225107348","doi":"https://doi.org/10.1080/14737167.2026.2755202","title":"COVID-19 and pharmaceutical sales in Karaman, Turkey (2019\u20132021): a hierarchical ATC analysis","display_name":"COVID-19 and pharmaceutical sales in Karaman, Turkey (2019\u20132021): a hierarchical ATC analysis","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225107348","doi":"https://doi.org/10.1080/14737167.2026.2755202","pmid":"https://pubmed.ncbi.nlm.nih.gov/42968534"},"language":"en","primary_location":{"id":"doi:10.1080/14737167.2026.2755202","doi":"https://doi.org/10.1080/14737167.2026.2755202","is_oa":false,"landing_page_url":"https://doi.org/10.1080/14737167.2026.2755202","pdf_url":null,"source":{"id":"https://openalex.org/S98544388","display_name":"Expert Review of Pharmacoeconomics & Outcomes Research","issn_l":"1473-7167","issn":["1473-7167","1744-8379"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Pharmacoeconomics & Outcomes Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068867176","display_name":"Ayta\u00e7 Kocaba\u015f","orcid":"https://orcid.org/0000-0001-7622-1932","observed_orcids":["https://orcid.org/0000-0001-7622-1932"]},"institutions":[{"id":"https://openalex.org/I46464968","display_name":"Karamano\u011flu Mehmetbey University","ror":"https://ror.org/037vvf096","country_code":"TR","type":"education","lineage":["https://openalex.org/I46464968"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Aytac Kocabas","raw_affiliation_strings":["Karamano\u011flu Mehmetbey University"],"raw_orcid":"https://orcid.org/0000-0001-7622-1932","affiliations":[{"raw_affiliation_string":"Karamano\u011flu Mehmetbey University","institution_ids":["https://openalex.org/I46464968"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053146450","display_name":"Mehmet Cabir Akkoyunlu","orcid":"https://orcid.org/0000-0002-9388-6554","observed_orcids":["https://orcid.org/0000-0002-9388-6554"]},"institutions":[{"id":"https://openalex.org/I46464968","display_name":"Karamano\u011flu Mehmetbey University","ror":"https://ror.org/037vvf096","country_code":"TR","type":"education","lineage":["https://openalex.org/I46464968"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Mehmet Cabir Akkoyunlu","raw_affiliation_strings":["Karamano\u011flu Mehmetbey University"],"raw_orcid":"https://orcid.org/0000-0002-9388-6554","affiliations":[{"raw_affiliation_string":"Karamano\u011flu Mehmetbey University","institution_ids":["https://openalex.org/I46464968"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5068867176"],"corresponding_institution_ids":["https://openalex.org/I46464968"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.82661993,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"1","last_page":"14"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11296","display_name":"COVID-19 and healthcare impacts","score":0.510699987411499,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11296","display_name":"COVID-19 and healthcare impacts","score":0.510699987411499,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11711","display_name":"COVID-19 Pandemic Impacts","score":0.40529999136924744,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.052000001072883606,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9850000143051147},{"id":"https://openalex.org/keywords/drug-sales","display_name":"drug sales","score":0.9940000176429749},{"id":"https://openalex.org/keywords/atc-classification","display_name":"ATC classification","score":0.7950000166893005},{"id":"https://openalex.org/keywords/community-pharmacy","display_name":"community pharmacy","score":0.6100000143051147},{"id":"https://openalex.org/keywords/hospital-pharmacy","display_name":"hospital pharmacy","score":0.8180000185966492},{"id":"https://openalex.org/keywords/sales-decline","display_name":"sales decline","score":0.593999981880188},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.8389999866485596}],"concepts":[{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.6424000263214111},{"id":"https://openalex.org/C127808970","wikidata":"https://www.wikidata.org/wiki/Q385989","display_name":"Bonferroni correction","level":2,"score":0.5952000021934509},{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.5037999749183655},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.4925000071525574},{"id":"https://openalex.org/C206041023","wikidata":"https://www.wikidata.org/wiki/Q1751970","display_name":"Wilcoxon signed-rank test","level":3,"score":0.4223000109195709},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3813999891281128},{"id":"https://openalex.org/C2777402240","wikidata":"https://www.wikidata.org/wiki/Q6783436","display_name":"Masking (illustration)","level":2,"score":0.34470000863075256},{"id":"https://openalex.org/C53059260","wikidata":"https://www.wikidata.org/wiki/Q374758","display_name":"Multilevel model","level":2,"score":0.34220001101493835},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.33730000257492065},{"id":"https://openalex.org/C122637931","wikidata":"https://www.wikidata.org/wiki/Q118084","display_name":"Unit (ring theory)","level":2,"score":0.33390000462532043},{"id":"https://openalex.org/C4679612","wikidata":"https://www.wikidata.org/wiki/Q866298","display_name":"Aggregate (composite)","level":2,"score":0.3310000002384186},{"id":"https://openalex.org/C3006700255","wikidata":"https://www.wikidata.org/wiki/Q81068910","display_name":"2019-20 coronavirus outbreak","level":3,"score":0.32829999923706055},{"id":"https://openalex.org/C21547014","wikidata":"https://www.wikidata.org/wiki/Q1423657","display_name":"Operations management","level":1,"score":0.325300008058548},{"id":"https://openalex.org/C33880087","wikidata":"https://www.wikidata.org/wiki/Q5275276","display_name":"Difference in differences","level":2,"score":0.31299999356269836},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.3066999912261963},{"id":"https://openalex.org/C99476002","wikidata":"https://www.wikidata.org/wiki/Q42297","display_name":"Analysis of variance","level":2,"score":0.3046000003814697},{"id":"https://openalex.org/C112758219","wikidata":"https://www.wikidata.org/wiki/Q16038819","display_name":"Duration (music)","level":2,"score":0.27459999918937683},{"id":"https://openalex.org/C2778058735","wikidata":"https://www.wikidata.org/wiki/Q4692253","display_name":"Aggregate data","level":2,"score":0.2703999876976013},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.2590999901294708},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.2522999942302704},{"id":"https://openalex.org/C102959455","wikidata":"https://www.wikidata.org/wiki/Q7313954","display_name":"Repeated measures design","level":2,"score":0.2513999938964844}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1080/14737167.2026.2755202","doi":"https://doi.org/10.1080/14737167.2026.2755202","is_oa":false,"landing_page_url":"https://doi.org/10.1080/14737167.2026.2755202","pdf_url":null,"source":{"id":"https://openalex.org/S98544388","display_name":"Expert Review of Pharmacoeconomics & Outcomes Research","issn_l":"1473-7167","issn":["1473-7167","1744-8379"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Pharmacoeconomics & Outcomes Research","raw_type":"journal-article"},{"id":"pmid:42968534","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42968534","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of pharmacoeconomics & outcomes research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W2582743722","https://openalex.org/W3012320055","https://openalex.org/W3025780634","https://openalex.org/W3027992628","https://openalex.org/W3040478087","https://openalex.org/W3048949857","https://openalex.org/W3090104885","https://openalex.org/W3154938279","https://openalex.org/W3166637691","https://openalex.org/W3170428885","https://openalex.org/W3187198111","https://openalex.org/W3211612101","https://openalex.org/W4200168787","https://openalex.org/W4283311939","https://openalex.org/W4283836156","https://openalex.org/W4320475034","https://openalex.org/W4377138253","https://openalex.org/W4382447643","https://openalex.org/W4385461548","https://openalex.org/W4389673035","https://openalex.org/W4390631756","https://openalex.org/W4394720243","https://openalex.org/W4400593702","https://openalex.org/W4402831954","https://openalex.org/W4402973874","https://openalex.org/W4407566958","https://openalex.org/W4409110987","https://openalex.org/W4409513082","https://openalex.org/W4409665036","https://openalex.org/W4410958572"],"related_works":["https://openalex.org/W3027992628","https://openalex.org/W4377194921","https://openalex.org/W3178858736","https://openalex.org/W4200168787","https://openalex.org/W3175992952","https://openalex.org/W4281646090","https://openalex.org/W4380992658","https://openalex.org/W4284971197","https://openalex.org/W4206998985","https://openalex.org/W4401977834"],"abstract_inverted_index":{"Background":[0],"The":[1,145],"COVID-19":[2],"pandemic":[3,146],"altered":[4],"pharmaceutical":[5,32,154],"consumption,":[6],"but":[7,119],"most":[8],"analyses":[9],"aggregated":[10],"sales":[11,33,83,167],"at":[12,86,168],"broad":[13,151],"therapeutic":[14],"levels,":[15],"masking":[16],"category-level":[17],"variation.":[18],"Evidence":[19],"from":[20,34],"middle-income":[21],"countries":[22],"remains":[23],"limited.Research":[24],"design":[25],"and":[26,38,66,71,79,110,183,186],"methods":[27],"This":[28],"retrospective":[29],"study":[30],"analyzed":[31],"10":[35],"community":[36],"pharmacies":[37],"one":[39],"hospital":[40,184],"pharmacy":[41],"unit":[42],"in":[43,89,95,116,153],"Karaman,":[44],"Turkey":[45],"(2019\u20132021).":[46],"Products":[47],"were":[48,74],"consolidated":[49],"using":[50],"ATC":[51,58,157,170],"code,":[52],"yielding":[53],"552":[54],"products":[55],"across":[56],"five":[57],"levels":[59,171],"(m":[60],"=":[61,92,124,135],"14\u2013552).":[62],"Paired":[63],"t-tests,":[64],"blocked":[65],"unrestricted":[67,117],"ANOVA,":[68],"Friedman":[69],"tests,":[70],"Wilcoxon":[72],"comparisons":[73],"performed":[75],"with":[76,108,121,140,149],"Benjamini\u2013Hochberg":[77],"(BH)":[78],"Bonferroni":[80],"corrections.Results":[81],"Aggregate":[82],"declined":[84,107,139],"significantly":[85],"Levels":[87],"2\u20135":[88],"2020":[90],"(BH-adjusted-p":[91],"0.014\u20130.042),":[93],"concentrated":[94],"the":[96,111,187],"first":[97],"half":[98],"of":[99,181],"2020,":[100],"not":[101],"persisting":[102],"into":[103],"2021.":[104],"Effect":[105],"sizes":[106],"depth":[109,141],"period":[112],"effect":[113],"was":[114,147],"undetected":[115],"ANOVA":[118],"significant":[120],"blocking":[122],"(p":[123],"0.017).":[125],"Nine":[126],"categories":[127],"declined;":[128],"only":[129],"antidiabetics":[130],"increased":[131],"(A10BD;":[132],"BH-adjusted":[133],"p":[134],"0.026).":[136],"Kendall\u2019s":[137],"W":[138],"(0.735":[142],"\u2192":[143],"0.077).Conclusions":[144],"associated":[148],"a":[150],"decline":[152],"sales.":[155],"Hierarchical":[156],"analysis":[158],"revealed":[159],"that":[160],"aggregate":[161],"patterns":[162],"masked":[163],"opposing":[164],"movements.":[165],"Monitoring":[166],"multiple":[169],"during":[172],"emergencies":[173],"is":[174],"recommended.":[175],"Limitations":[176],"include":[177],"non-random":[178],"sampling,":[179],"exclusion":[180],"online":[182],"medications,":[185],"inability":[188],"to":[189],"establish":[190],"causality.":[191]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-11-03T00:00:00"}